A Pretherapy Biodistribution and Dosimetry Study of Indium-111-Radiolabeled Trastuzumab in Patients with Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer

PURPOSE: The purposes of this study were to evaluate the organ biodistribution, pharmacokinetics, immunogenicity, and tumor uptake of (111)Indium ((111)In)-MxDTPA-trastuzumab in patients with human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancers and to determine whether (90)Y...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wong, Jeffrey Y.C., Raubitschek, Andrew, Yamauchi, Dave, Williams, Lawrence E., Wu, Anna M., Yazaki, Paul, Shively, John E., Colcher, David, Somlo, George
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mary Ann Liebert, Inc. 2010
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2958439/
https://ncbi.nlm.nih.gov/pubmed/20707718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2010.0783
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi